Cohort 8

NeoPurpose Therapeautics, Inc.

NeoPurpose Therapeautics, a revolutionary cancer drug discovery platform, utilizes 3D bioprinting to develop tumor-on-a-chip models. The advanced patented technology enables more accurate drug screening, reducing the reliance on traditional animal models and improving clinical translation. These models replicate the tumor microenvironment, allowing pharmaceautical companies and research laboratories to conduct more predictive drug screenings, accelerate development timelines, and reduce costs. 

The Team

Sanjay K. Srivastava, President, Founder

Mohamed Eltokhy, CEO, Co-Founder

Marina Curcic, CTO, Co-Founder

 

Mentors

Mike Ryan, Lead, Staff Liason

Mark Murdock

Sarah Simpson

Netaji Knot

Tim Dallas

John Smothers

Nick Bergfeld, Executive Coach